References

Descriptive Epidemiology of the Head and Neck Cancers in Old Patients

10.3389/fonc.2023.1102236 · 2023 · External reference

Cancer Treatment and Survivorship Statistics, 2016

2016 · External reference

Cisplatin‐Induced Ototoxicity: Effects, Mechanisms and Protection Strategies

10.3390/toxics3030268 · 2015 · External reference

The Long‐Term Impacts of Hearing Loss, Tinnitus and Poor Balance on the Quality of Life of People Living With and Beyond Cancer After Platinum‐Based Chemotherapy: A Literature Review

10.1007/s11764-022-01314-9 · 2023 · External reference

Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission

10.1016/s0140-6736(24)01296-0 · 2024 · External reference

Age‐Related Hearing Loss and Its Potential Drug Candidates: A Systematic Review

10.1186/s13020-023-00825-6 · 2023 · External reference

Understanding Platinum‐Induced Ototoxicity

10.1016/j.tips.2013.05.006 · 2013 · External reference

Cisplatin‐Associated Ototoxicity: A Review for the Health Professional

10.1155/2016/1809394 · 2016 · External reference

Evaluation of Geriatric Assessment and Management on the Toxic Effects of Cancer Treatment (GAP70+): A Cluster‐Randomised Study

10.1016/s0140-6736(21)01789-x · 2021 · External reference

Prevalence, Age‐Standardized Prevalence, and Incidence Rates of Bilateral High‐Frequency Hearing Loss Among Japanese Individuals Undergoing Comprehensive Health Checkup System (Ningen Dock) From 2014 to 2020: A Descriptive Study

2025 · External reference

Distortion‐Product Otoacoustic Emission Test Performance for Ototoxicity Monitoring

10.1097/aud.0b013e3181e8b6a7 · 2011 · External reference

Audiological Methods for Early Detection of Hearing Loss in Healthcare Worker

10.3390/healthcare13101113 · 2025 · External reference

Guidelines for the Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy

1994 · External reference

Test–Retest Repeatability of Distortion Product Otoacoustic Emissions

10.1097/aud.0b013e31816906e7 · 2008 · External reference

Epidemiological Profile of Hearing Impairments: The Scale and Nature of the Problem With Special Reference to the Elderly

1990 · External reference

Mechanisms of Cisplatin Ototoxicity and Routes for Intervention

10.1044/hhd15.1.3 · 2011 · External reference

The Relationship Between Cisplatin‐Related and Age‐Related Hearing Loss During an Extended Follow‐Up

10.1002/lary.28543 · 2020 · External reference

Risk Factors of Ototoxicity After Cisplatin‐Based Chemo‐Irradiation in Patients With Locally Advanced Head‐And‐Neck Cancer: A Multivariate Analysis

10.1016/j.ijrobp.2007.01.042 · 2007 · External reference

Sensorineural Hearing Loss in Combined Modality Treatment of Nasopharyngeal Carcinoma

10.1002/cncr.21683 · 2006 · External reference

Hearing Loss due to Concurrent Daily Low‐Dose Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer

10.1016/j.radonc.2008.06.003 · 2008 · External reference

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin‐Based Chemotherapy in Survivors of Adult‐Onset Cancer

10.1200/jco.2016.66.8822 · 2016 · External reference

Consonant Recognition Loss in Hearing Impaired Listeners

10.1121/1.3238257 · 2009 · External reference

High‐Frequency Audibility: The Effects of Audiometric Configuration, Stimulus Type, and Device

10.3766/jaaa.26.2.3 · 2015 · External reference

Radiation Therapy and Hearing Loss

10.1016/j.ijrobp.2009.04.096 · 2010 · External reference

Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer With Cochlear‐Sparing Intensity‐Modulated Radiation Therapy

10.3390/cancers16122228 · 2024 · External reference

Treatment‐Related Hearing Loss in Weekly Versus Triweekly Cisplatin Chemoradiation for Head and Neck Cancer

10.1007/s00405-024-08880-x · 2024 · External reference

Lower, More Frequent Cisplatin Dosing Minimizes Hearing Loss in Head and Neck Cancer

10.1172/jci.insight.196230 · 2025 · External reference